{"page_content": "Notes\nNote 10 \u2013 Financial expenses\n Accounting policies\nFinancial expenses include in\nterest expenses, as well as realized and unrealized exchange rate adjust-\nments, interest on lease obligations and fair value adjustments of securities.\nInterest expense is recognized in the income statement in accordance with the effective interest rate \nmethod.\nDKK thousand    2021  2020  2019\nInter\nest expenses \n   -4\n,091\n -2,\n895\n -3\n,205\nFair value adjustments of marketable securities, cf. note 22\n  0\n -2,103\n 0\nF\nair value adjustments of other investments, cf. note 16\n  -8\n,217\n 0\n 0\nOther financial expenses\n   -3\n,473\n -4\n,829\n -185\nEx\nchange rate adjustments (primarily on USD deposits)\n  0\n -39\n,487\n 0\nT\notal financial expenses\n   -15\n,781\n -49\n,314\n -3\n,39070\nZealand Pharma  \u221e  Annual Report 2021Con Fin \u2013 Note 10 NY", "metadata": {"source": "NASDAQ_ZEAL_2021.pdf", "page": 69, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}